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Objective: The objective of this meta-analysis was to evaluate the effect of motivational
interviewing (MI) on self-management in patients with type 2 diabetes.
Methods: Randomised controlled trials that assessed the effects of MI on self-management
and HbA1c levels in patients with type 2 diabetes were systematically reviewed using
multiple electronic databases. Weighted mean differences with 95% confidence intervals
were calculated for continuous data.
Results: Ten trials were included in this meta-analysis. The self-management ability of pa-
tientswith type 2 diabeteswho underwentMIwas significantly better than that of patients in
the control group (WMD, 2.37; 95% CI, 1.77e2.98; p < 0.00001). Subgroup analysis showed that
short-termMI (6 months) resulted in a significant decrease in the HbA1c level (p < 0.05) but
that this advantage was not present for relatively long-term MI (>6 months) (p > 0.05).
Conclusions: MI was associated with improved self-management abilities among patients
with type 2 diabetes, and short-term MI (6 months) effectively decreased the HbA1c level.
The effect of long-term MI (>6 months) on the HbA1c level remains uncertain. Large-scale,
higher-quality randomised controlled trials are needed to confirm the present findings.
Copyright © 2014, Chinese Nursing Association. Production and hosting by Elsevier
(Singapore) Pte Ltd. All rights reserved.1. Introduction
The prevalence of type 2 diabetes is rapidly increasing due to
population ageing and lifestyle changes [1]. Self-management
is the basis for treatment of type 2 diabetes and is critical in
the prevention of complications. Nurse-led health education
has been one of the most important methods of helping these
patients to strengthen their self-management abilities [2].un).
Nursing Association.
g Association. ProductionHowever, a previous study showed that health education
programmes that provide traditional advice have a success
rate of only 5%e10% [3]. Therefore, effective new approaches
to helping patients improve their self-management abilities
are urgently needed. Motivational interviewing (MI) is a
patient-centred behaviour-changing strategy that aims to
identify and reduce patient ambivalence regarding health
behaviour changes and improve patients' perceptions of the
importance of behaviour changes [4,5]. MI is valuable in theand hosting by Elsevier (Singapore) Pte Ltd. All rights reserved.
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including type 2 diabetes [6]. Recent studies have shown that
MI can contribute to improvements in self-management
abilities in patients with type 2 diabetes [7,8]. However,
many professionals remain concerned about the applicability
of these results because of the great variation in interven-
tional designs and questionable evaluation indices. Therefore,
we conducted the present meta-analysis to assess the effects
of MI on the self-management ability of patients with type 2
diabetes and to provide evidence for the use of MI in nursing
practice.2. Design and method
2.1. Inclusion and exclusion criteria
2.1.1. Study type
Randomised controlled trials (RCTs) in both Chinese and En-
glish were eligible for inclusion in this meta-analysis.
2.1.2. Study objective
Patients with type 2 diabetes aged >18 years who were able to
independently care for themselves were eligible for inclusion
in this study. Patients with other severe medical conditions or
complications such as stroke, malignant tumours, ketoaci-
dosis, or critical diabetic nephropathy were excluded.
2.1.3. Study intervention
MI was provided to patients in the study group. Trained and
qualified professionals acted as the interviewers. The inter-
vention plan was formulated by the interviewer and generally
comprised two steps. First, the patients were assisted in
strengthening their internal motive for behaviour changes.
Second, the patients were assisted in consolidating their
commitment to and carrying out the plan for these behaviour
changes. Self-managementerelated knowledge was intro-
duced to the patients in the control group using traditional
health education methods, such as collective classes.
2.1.4. Outcome measures
The primary outcomes were the HbA1c level (%) and the self-
management ability. Themeasurement tools used to evaluate
the self-management ability included the Summary of Dia-
betes Self-Care Activities (SDSCA) and the Type 2 Diabetes
Self-Care Scale (2-DSCS).2.2. Search strategy
Medline, PubMed, JBI Library, CINAHL, EMBASE, the Cochrane
Library, CNKI, VIP, Wanfang, Google, and Google Scholar were
electronically searched up to January 2014 using combinations
of the following search terms: “diabetes,” “motivational
interviewing,” “self-care,” “self-management,” and “behavior
change.” The titles, abstracts, and reference lists of all iden-
tified reports were independently examined by D.S. and T-Z
X.. Disagreements were resolved by discussion or consensus
with Q-H. S..2.3. Assessment of methodological quality
The methodological quality of all RCTs was graded with the
Cochrane Handbook, version 5.1.0, which assesses studies
according to the method of randomisation, adequacy of allo-
cation concealment, blinding of outcome assessment, pro-
portion of patients lost to follow-up, performance of
intention-to-treat analysis, and comparability of baseline
data. The risk of bias in each RCT was graded from A to C,
where A, B, and C indicated low, medium, and high risk,
respectively. All disagreements were resolved by discussion.
2.4. Data extraction
We independently extracted data from all studies using
standardised forms. These data included the study design,
sample size, type of procedure, numbers and reasons for
withdrawals and dropouts, and all aforementioned outcome
variables. All disagreements regarding values or analysis were
resolved by discussion.
2.5. Statistical analysis
This meta-analysis was conducted using RevMan 5.2.0 soft-
ware (Cochrane Collaboration, Oxford, UK). Data were evalu-
ated bymeans of weightedmean differences (WMDs) and 95%
confidence intervals (CIs). Heterogeneity was explored by the
I2 test. If I2 < 50%, a fixed-effects model was employed;
otherwise, a random-effects model was used. Subgroup
analysis was performed according to the heterogeneous fac-
tors considered. A narrative overview was conducted when
synthesis was inappropriate.3. Results
3.1. Study selection
The initial search strategy generated 427 studies. After
screening all titles and abstracts, we identified 23 potentially
eligible trials. On further assessment, 13 trials were excluded
because they either did not meet the inclusion criteria or met
the exclusion criteria. Finally, 10 trials [7e16] involving 2947
patients were included in this meta-analysis. The details of
the included trials are summarised in Table 1.
3.2. Methodological quality
The results of the methodological quality assessment of all
included trials are shown in Table 2.
3.3. Primary outcomes
3.3.1. Effects of MI on HbA1c level
All 10 trials [7e16] reported assessment of the effects of MI on
the HbA1c level. One trial [15] was excluded because it did not
mention the intervention time. A subgroup analysis was
performed according to the intervention period (3, 6, 12, 14, 18,
or 24 months). The heterogeneity test result revealed an I2 of
>50%; thus, a random-effects model was used.
Table 1 e Characteristics of studies included in the present meta-analysis.
Study Participants,
n (intervention/control)
Period Intervention Control Time of assessment Indicator





6, 12, and 18 months of
intervention
HbA1c
Welch 2011 [8] 115 (57/58) 6 months Frequency: 3 MI sessions, 30 min/session
Interviewer: trained nursing staff
Traditional diabetes
health education
End of intervention HbA1c
Gabbay 2013 [9] 545 (232/313) 18 months Frequency: 8 MI sessions, 1 h/session
Interviewer: trained nursing staff
Traditional diabetes
health education
12 and 24 months of
intervention
HbA1c
Rubak 2011 [10] 628 (307/321) 12 months Frequency: 3 MI sessions, 45 min/session
Interviewer: trained nursing staff
Traditional diabetes
health education
End of intervention HbA1c
Brug 2007 [11] 142 (83/59) 6 months Frequency: 4e5 MI sessions, 30e45 min/session
Interviewer: trained nursing staff
Traditional diabetes
health education
End of intervention HbA1c
Jansink 2013 [12] 940 (422/518) 14 months Frequency: not mentioned
Interviewer: trained nursing staff
Traditional diabetes
health education
End of intervention HbA1c
Zhang 2012 [13] 80 (40/40) 6 months Frequency: 8 phone MI sessions in the
first 2 months, 6 personal MI sessions in
the next 3 months, 1 phone and 1 personal
MI session in the last month;
30e45 min/session of personal MI,










Wang 2011 [14] 80 (40/40) 6 months Frequency: 4 personal MI sessions in
the first month, 5 phone MI and 5
personal MI sessions in the next 5 months;
30 min/session of personal MI,
20 min/session of phone MI
Interviewer: trained nursing staff
Traditional diabetes
health education




YE 2012 [15] 120 (60/60) e Frequency: not mentioned
Interviewer: trained nursing staff
Traditional diabetes
health education




Zou 2013 [16] 80 (40/40) 6 months Frequency: 2e3 sessions of personal
MI in hospital, 2 phone MI sessions
after discharge; 30 min/session of
personal MI, 20 min/session of phone MI
Interviewer: trained nursing staff
Traditional diabetes
health education






MI ¼ motivational interviewing; 2-DSCS ¼ Type 2 Diabetes Self-Care Scale;

















































Table 2 e Evaluation of the methodological quality of included studies included.







West 2007 [7] Random number table Yes Yes Yes Yes No difference A
Welch 2011 [8] Random number table Not clear Not clear Yes No No difference B
Gabbay 2013 [9] Random number table Yes Yes Yes Yes No difference A
Rubak 2011 [10] Random number table Not clear Not clear Yes No No difference B





Not clear Not clear Yes No No difference B
Zhang 2012 [13] Random number table Not clear Not clear No No No difference B
Wang 2011 [14] Random number table Not clear Not clear No No No difference B
Ye 2012 [15] Random number table Not clear Not clear Not clear No No difference B
Zou 2013 [16] Random number table Not clear Not clear No No No difference B
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[13,16] assessed the effect of 3 months of MI on the HbA1c
level. After 3 months of MI, the HbA1c level was significantly
lower in the intervention group than in the control group
(WMD, e0.66; 95% CI, e1.02 to 0.30; p ¼ 0.0003) (Fig. 1).
3.3.1.2. Effect of 6 months of MI on HbA1c level. Six trials
[7,8,11,13,14,16] assessed the effect of 6 months of MI on the
HbA1c level. After 6 months of MI, the HbA1c level was
significantly lower in the intervention group than in the con-
trol group (WMD, e0.44; 95% CI, e0.73 to 0.15; p ¼ 0.003)
(Fig. 1).
3.3.1.3. Effect of 12 months of MI on HbA1c level. Two trials
[7,10] assessed the effect of 12 months of MI on the HbA1c
level. After 12 months of MI, no significant difference in the
reduction of the HbA1c level was observed between the
intervention and control groups (WMD, 0.10; 95% CI, e0.04 to
0.23; p ¼ 0.16) (Fig. 1).
3.3.1.4. Effect of 14 months of MI on HbA1c level. One trial [12]
assessed the effect of 14 months of MI on the HbA1c level.
After 14 months of MI, no significant difference in the reduc-
tion of theHbA1c level was observed between the intervention
and control groups (WMD, 0.10; 95% CI, 0.25 to 0.05; p ¼
0.19) (Fig. 1).
3.3.1.5. Effect of 18 months of MI on HbA1c level. One trial [7]
assessed the effect of 18 months of MI on the HbA1c level.
After 18 months of MI, no significant difference in the reduc-
tion of the HbA1c level was observed between the two groups
(WMD, 0.00; 95% CI, e0.28 to 0.28; p ¼ 1.00) (Fig. 1).
3.3.1.6. Effect of 24 months of MI on HbA1c level. One trial [9]
assessed the effect of 24 months of MI on the HbA1c level.
After 24 months of MI, no significant difference in the reduc-
tion of theHbA1c level was observed between the intervention
and control groups (WMD, 0.20; 95% CI, 0.50, 0.10; p ¼ 0.19)
(Fig. 1).
3.3.2. Effect of MI on self-management ability
Four trials [13e16] assessed the effect of MI on patients' self-
management ability, which comprises six aspects: control of
diet, regular exercise, adherence to medications, glucosemonitoring, foot care, and prevention and treatment of
hyperglycaemia and hypoglycaemia. One study [16] per-
formed measurements using the SDSCA, developed by Too-
bert et al. [17]; the other three studies [13e15] performed
measurements using the 2-DSCS. Therefore, a meta-analysis
was performed for these three trials, and the other one was
described separately. The heterogeneity test result showed an
I2 of >50%; thus, a random-effects model was employed. Ac-
cording to the results, the MI intervention resulted in a
significantly greater improvement in all aspects of the self-
management ability in the intervention group than in the
control group (WMD, 2.37; 95% CI, 1.77e2.98; p < 0.00001) with
the exception of adherence to medications (WMD, 1.53; 95%
CI, e0.1 to 3.16; p ¼ 0.07) (Fig. 2). Likewise, the one study [16]
that performed measurements using the SDSCA reported
that 3 and 6 months of MI significantly improved all six as-
pects of patients' self-management ability (p < 0.05).4. Discussion
4.1. Methodological quality
The 10 studies included in this meta-analysis varied in
research quality; only three [7,9,11] were considered to be
high-quality studies. This result was caused by a lack of pre-
ciseness in the research design: one trial [12] did not describe
the randomisation method, and one trial [12] did not report
the number of patients lost to follow-up. The three high-
quality trials [7,9,11] adopted blinding, allocation conceal-
ment, and intention-to-treat analysis.
4.2. Short-term MI can reduce the HbA1c level
The findings of the present meta-analysis indicate that short-
termMI (6months) more effectively reduced the HbA1c level
than did the control interventions; however, this advantage
disappeared with relatively longer-term MI (12e24 months).
Two possible reasons for these findings may be considered.
First, as found by a previous study [18], the positive effects of
diabetes education may gradually weaken with time. Second,
a limited number of studies were included in this meta-
analysis, and most did not last more than 1 year; thus, only
a few studies were included in the combined analysis.
Fig. 1 e Efficacy of MI for reduction of HbA1c at different time points (random-effects model).
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The present study assessed six aspects of the self-
management ability among patients with type 2 diabetes:
diet control, regular exercise, adherence to medications,
glucose monitoring, foot care, and prevention and treatment
of hyperglycaemia and hypoglycaemia. Compared with the
control group, MI resulted in a significantly greater improve-
ment in the patients' level of self-management ability in all
aspects with the exception of adherence to medication. We
separately evaluated the three studies [13e15] that assessed all
six aspects of self-management ability. In two of these studies
[13,14], MI resulted in a significantly greater improvement inadherence to medication in the MI group than in the control
group (p < 0.05); the remaining study [15] showed no difference
between the two groups. One study [16] that performed mea-
surements using the SDSCA but that was not included in the
meta-analysis also indicated that MI can significantly improve
patients' adherence to medications (p < 0.05). Therefore, the
effects of MI on adherence to medications require confirma-
tion by additional high-quality studies.
4.4. Limitations
Only reports written in English and Chinese were included
because of language limitations. Additionally, a relatively
Fig. 2 e Efficacy of MI for improvement in self-management ability (random-effects model).
i n t e r n a t i o n a l j o u rn a l o f n u r s i n g s c i e n c e s 1 ( 2 0 1 4 ) 2 9 1e2 9 7296inadequate number of studies was included for each different
index because of the variation in the evaluation indices and
measurement tools used among the studies. However, the
measurement tools of the included studies exhibited high
reliability and fair validity, and the sample of the combined
analysis was very large (n ¼ 2947); both of these factors
contributed to the reliability and accuracy of our study.4.5. Implications for further study
The results of the present study indicate that MI is superior to
traditional interventions in improving the self-management
abilities of patients with type 2 diabetes. The study also
showed that short-termMI (6months) is more effective than
control interventions for reduction of the HbA1c level, but that
i n t e r n a t i o n a l j o u r n a l o f nu r s i n g s c i e n c e s 1 ( 2 0 1 4 ) 2 9 1e2 9 7 297the effect of relatively longer-term MI (>6 months) on reduc-
tion of the HbA1c level requires further research. High-quality
RCTs with large samples are required to increase the evidence
in support of the advantages of MI. The intervention period is
relatively short in previous studies on this subject and should
be lengthened in future studies. Such longitudinal studies will
allow the effects of MI at different intervention phases to be
studied in more detail. Finally, although qualitative materials
are very important in nursing research, very few such studies
were found on this subject. Qualitative studies are needed to
ascertain the benefits of MI over traditional intervention and
provide higher-quality study content with more accurate
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